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Bonsignore, Maria R., Giuseppe Morici, Alessandra
Santoro, Maria Pagano, Lucia Cascio, Anna Bonanno,
Pietro Abate, Franco Mirabella, Mirella Profita, Giu-
seppe Insalaco, Maria Gioia, A. Maurizio Vignola, Ig-
nazio Majolino, Ugo Testa, and James C. Hogg. Circu-
lating hematopoietic progenitor cells in runners. J Appl
Physiol 93: 1691–1697, 2002. First published July 12, 2002;
10.1152/japplphysiol.00376.2002.—Because endurance exer-
cise causes release of mediators and growth factors active on
the bone marrow, we asked whether it might affect circulat-
ing hematopoietic progenitor cells (HPCs) in amateur run-
ners [n  16, age: 41.8  13.5 (SD) yr, training: 93.8  31.8
km/wk] compared with sedentary controls (n 9, age: 39.4
10.2 yr). HPCs, plasma cortisol, interleukin (IL)-6, granulo-
cyte colony-stimulating factor (G-CSF), and the growth factor
fms-like tyrosine kinase-3 (flt3)-ligand were measured at rest
and after a marathon (M; n  8) or half-marathon (HM; n 
8). Circulating HPC counts (i.e., CD34 cells and their sub-
populations) were three- to fourfold higher in runners than in
controls at baseline. They were unaffected by HM or M
acutely but decreased the morning postrace. Baseline corti-
sol, flt3-ligand, IL-6, and G-CSF levels were similar in run-
ners and controls. IL-6 and G-CSF increased to higher levels
after M compared with HM, whereas cortisol and flt3-ligand
increased similarly postrace. Our data suggest that increased
HPCs reflect an adaptation response to recurrent, exercise-
associated release of neutrophils and stress and inflamma-
tory mediators, indicating modulation of bone marrow activ-
ity by habitual running.
cytokines; growth factors; marathon; endurance training
ALTHOUGH EXERCISE IS CONSIDERED a physiological stimu-
lus for cell release by the bone marrow (5), surprisingly
few data are available on circulating hematopoietic
precursors in athletes. Erythrocyte production was
studied relative to athlete’s anemia (25) and to assess
the effects of intermittent hypoxic exposure on exercise
performance (1). Conversely, little is known of the
effects of exercise on myeloid precursors. Over 20 years
ago, it was reported that colony-forming cells in periph-
eral blood increased after a short and intense exercise
bout in normal subjects (2), but a detailed character-
ization of hematopoietic precursors in well-trained sub-
jects was never obtained.
The rationale to study myeloid precursors in athletes
is that intense and prolonged exercise increases white
blood cell (WBC) and neutrophil [polymorphonuclear
neutrophil (PMN)] counts (5, 16), partly through mo-
bilization of marginated PMNs (5) associated with in-
creased endogenous plasma glucocorticoids (15). PMN
activation also occurs during exercise, as indicated by
increased plasma PMN elastase (8). In addition, endur-
ance exercise causes release of hormones, such as cor-
tisol and growth hormone (24), and mediators, such as
tumor necrosis factor (TNF)-, interleukin (IL)-6, and
granulocyte colony-stimulating factor (G-CSF) (17), all
known to promote the growth and release of hemato-
poietic progenitor cells (HPCs) (11). Whether exercise
may cause release of other hematopoietic growth fac-
tors, such as fms-like tyrosine kinase-3 (flt3)-ligand,
known to potently induce the growth and differentia-
tion of HPCs in vivo and in vitro (13), has not been
assessed.
As for training-induced adaptations, exercise-in-
duced neutrophilia was shown to become progressively
blunted with training (22, 23), but no study ever tested
whether circulating HPC counts may differ between
trained and sedentary subjects. Circulating immature
cells are likely involved in angiogenesis (19) and repair
processes (21), both mechanisms being possibly associ-
ated with strenuous exercise and progressive training.
Given the large use of exercise-based rehabilitation
programs in several diseases, knowledge of the physi-
ological effects of training on HPCs might be of poten-
tial clinical use.
In this study, we measured circulating CD34-posi-
tive (CD34) cells and their subpopulations in healthy
amateur runners. CD34 cells are early HPCs with
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undifferentiated morphology, whose maturation steps
are indicated by progressive acquisition of CD38, hu-
man leukocyte antigen (HLA)-DR, and CD33 markers.
Eventually, these cells lose the CD34 marker as they
enter the differentiation pathway, thereby developing
lineage-specific features (26). Baseline HPC counts in
runners, likely to reflect chronic, training-associated
changes, were compared with data from sedentary
controls. The response of HPCs to exercise was as-
sessed by studying the same runners at the end of the
1999 Palermo International marathon (M) or half-mar-
athon (HM), respectively, and the following morning.
This experimental design was chosen to analyze
whether amount or duration of endurance exercise
could modulate inflammatory and stress mediators, as
well as circulating HPC counts.
METHODS
Subjects. Sixteen male amateur runners participating in
the 5th Palermo International M (n  8) or HM (n  8) were
studied. The entire group had a mean age of 41.3  13.4 yr
and a racing experience of 11  9 yr (range 1–35 yr). Mean
body weight and height were 70  7 kg and 173  5 cm,
respectively. On average, the HM and M groups trained 89
32 and 99  33 km/wk, respectively (not significant). M and
HM runners differed significantly for age (M: 50.4  9.5 yr,
HM: 33.1  11.5 yr; P  0.005 by unpaired t-test). Nine
sedentary healthy men (age 39.4  10.2 yr, body weight 82 
9 kg, height 178 6 cm) were studied at baseline as controls.
All subjects were nonsmokers, clinically healthy, and with no
history of recent infection or other disease. The protocol was
approved by the local Ethics Committee, and all subjects
gave written informed consent to the study.
M and HM. The 5th Palermo International M and HM
were held on December 8, 1999 at sea level. The race began
at 9:00 AM. Weather conditions were good (mean hourly data
from 9:00 AM to 1:00 PM by the City of Palermo Weather
Bureau: barometric pressure: 1,007 mbar; temperature:
12.1  1.7°C; wind: 0.73  0.24 m/s; solar irradiation:
315.6  60.9 W/m2). Runners were allowed free intake of
water during the race. Mean race time was 79 7 min (range
69–91 min) in the HM group, and 207  38 min (range
159–254 min) in the M group.
Protocol and measurements. Runners were studied under
baseline conditions 9  2 days before the race, shortly (13 
7 min) after completion of the race, and the next morning. On
the day of the race, blood samples were obtained at the finish
line and kept at 4°C during transportation to the V. Cervello
Hospital in Palermo, where they were immediately pro-
cessed. All other samples in runners and controls were col-
lected at the hospital in the morning in fasting conditions,
kept at 4°C, and immediately processed.
Blood was drawn from the subject’s antecubital vein into
sterile tubes containing EDTA (Vacutainer, Becton Dickin-
son, San Jose, CA) for complete blood cell counts (ADVIA
counter, Bayer) and analysis of HPC by cytofluorimetry. For
surface marker analysis, peripheral blood samples were an-
alyzed for the expression of the CD34 (human progenitor cell
antigen-2 FITC), CD38 (Leu-17 phycoerythrin), CD33
(LeuM9 phycoerythrin), and HLA-DR (HLA-DR peridinin
chlorophyll protein) antigens (Becton Dickinson) by using
three-color staining. Ig isotype-negative controls were used.
The samples were immunofluorescence labeled, and flow
cytometry was performed on a FACScan Excalibur with
CellQuest software (Becton Dickinson). Analysis was per-
formed by using large contiguous gates on lymphocyte and
monocyte regions (7). The percentage of CD34 cells was
calculated by adding the percentage of CD34 cells on the
lymphocyte and monocyte gates and subtracting the percent-
age of cells stained with the control reagents. The number of
total cells acquired was 50,000 to ensure adequate sensitivity
of the analysis. Total CD34 cells were determined in tripli-
cate in each subject, because three samples (for CD34/CD38,
CD34/HLA-DR, and CD34/CD33 antigens) were analyzed;
the mean value was used for analysis. Variability for total
CD34 cell counts was estimated by calculating the coeffi-
cient of variation in each subject. Circulating reticulocytes
were also determined by the microscopic brilliant cresyl blue
method.
In each experimental condition, aliquots of plasma and
serum were collected and stored at 80°C. Muscle enzymes
[lactic dehydrogenase (LDH) and creatine kinase (CK)] and
serum iron were measured by enzymatic assays (Olympus
640 kits and equipment, Olympus Diagnostica, Hamburg,
Germany). Total plasma elastase was measured by a homo-
geneous enzyme immunoassay specific for human PMN elas-
tase (detection threshold: 4 g/l; Ecoline kit, Merck, Darm-
stadt, Germany). Serum cortisol was measured by
radioimmunoassay (sensitivity 0.36 mg/dl; Immunotech,
Marseille, France). Plasma levels of TNF-, IL-6, G-CSF,
flt3-ligand, and erythropoietin (EPO) were measured by im-
munoassay (R&D Systems Europe, Abingdon, UK). High-
sensitivity kits were used for TNF- (sensitivity: 0.18 pg/ml)
and G-CSF (sensitivity: 0.8 pg/ml). The lower detection limit
of the IL-6 assay was 0.7 pg/ml, and this value was used in
statistical analysis for samples with undetectable IL-6 levels.
Lower detection limits for the other assays were 7 pg/ml for
flt3-ligand and 0.6 mIU/ml for EPO.
Statistics. All data are reported as means  SD. Runners
and controls at baseline were compared by unpaired t-test
(normally distributed variables) and Mann-Whitney test
(CD34 cell counts). Data obtained at different time points in
runners were analyzed by repeated-measures ANOVA or
paired t-test with Bonferroni correction for post hoc compar-
isons. Relationships between variables were analyzed by
simple linear regression. The statistical analysis package
used was Statview 4.5 (Abacus Concept, Berkeley, CA). Sig-
nificance was set at P  0.05.
RESULTS
Baseline conditions. Table 1 reports main data on
blood cell counts in runners and controls. Serum iron
concentration was in the normal range in both groups,
but circulating reticulocytes in runners were about
one-half the value of controls (P  0.0005). Total and
differential WBC counts did not differ between groups.
Circulating CD34 cells (Fig. 1, Table 2) were three
to four times higher in runners compared with con-
trols, without significant differences between M and
HM groups for total CD34 cells or any subpopulation.
Two HM runners showed very high total CD34 cell
counts, accounting for the trend toward higher values
in the HM compared with M group (individual total
CD34 cell counts at baseline are reported in the x-axis
of Fig. 2A). CD34/CD38 cells were very low in run-
ners and controls, whereas total CD34 and all other
subpopulations were increased in runners. The coeffi-
cient of variation for total CD34 cell counts was 9.5 
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7.0% in runners and 13.2  10.6% in controls (differ-
ence not significant).
In runners, red blood cell counts were inversely cor-
related to training volume, estimated as kilometers per
week (r  0.51, P  0.05). Neither circulating CD34
cell or reticulocyte counts at baseline correlated with
age or training volume. When the analysis of CD34
cell counts was repeated after excluding two HM run-
ners showing high baseline CD34 counts (see above),
results of regression analyses did not change.
M and HM. Total WBC and PMN counts increased
after the race, more after M than after HM (Table 1).
Reticulocyte counts doubled after both M and HM
(Table 1). All values had returned to baseline value by
the morning after the race.
Total circulating CD34 cells or subpopulations at
the end of the M or HM were unchanged compared
with baseline (Table 2). The coefficients of variation for
total CD34 counts at the end of M and HM were
12.8 9.1 and 11.7 11.2%, respectively (not different
from baseline or control values).
In individual runners, the change in total CD34
count at the end of the race was smallest in subjects
with the highest baseline counts (r  0.862, P 
0.0001 for pooled HM and M data; Fig. 2A). Absolute
CD34 counts after the race did not correlate with
training volume, but their change at the end of the race
was smallest in M runners with the highest training
volume (r  0.88, P  0.005 in the M group; Fig. 2B).
Markers of muscle damage, stress, and inflamma-
tion. Muscle enzymes at baseline were higher in run-
ners (LDH: 352  90 U/l; CK: 290  173 U/l) than in
controls (LDH: 288  36 U/l; CK: 110  69 U/l; P 
0.05 and 0.01, respectively, vs. runners). LDH in-
creased immediately postrace (M: 523  133 U/l; HM:
438  84 U/l; P  0.001 vs. baseline), whereas CK
increased markedly on the day after the race (M:
1,279  1,049 U/l; HM: 944  856 U/l; P  0.005 vs.
baseline), without significant differences between M
and HM runners.
Figure 3 summarizes the plasma levels of total neu-
trophil elastase, TNF-, IL-6, G-CSF, cortisol, and flt3-
ligand in all groups and experimental time points. At
baseline, runners and controls were similar, but flt3-
ligand was lower in HM than M runners, possibly due
to an age effect (flt3-ligand vs. age: controls, r  0.76;
runners, r  0.63; P  0.05 for both). TNF-, PMN
elastase, cortisol, and flt3-ligand increased after the
race, irrespective of M and HM distance. Conversely,
IL-6 and G-CSF increased more after M (40-fold and
3-fold, respectively) than after HM (10-fold and by
47%, respectively). EPO was unchanged after the race.
In runners, plasma cortisol was positively associated
with G-CSF (r  0.76, P  0.0001) and flt3-ligand (r 
0.71, P  0.001), whereas its association with IL-6 was
less consistent (r  0.76, P  0.05 in post-M samples
only). Weaker associations were found between cortisol
and markers of inflammation (TNF-: r  0.56, elas-
tase: r  0.72, P  0.001 for both). Plasma cortisol
correlated with WBC (r 0.82, P 0.0001), neutrophil
(r  0.83, P  0.0001), and reticulocyte counts (r 
0.61, P  0.0001) but not with CD34 cell counts.
Both TNF- and PMN elastase correlated with flt3-
ligand (r 0.76 and 0.66, respectively; P 0.0001) and
reticulocyte counts (r 0.47 and 0.66, respectively; P
0.001) but not with CD34 cell counts.
Morning postrace. In both HM and M groups, total
CD34 cell counts were lower on the morning postrace
(Table 2) compared with end of the race (pooled data:
Table 1. Blood cell counts in sedentary controls and runners
Condition
RBC,
cells  106/l
Hct,
%
Reticulocytes,
%RBC
WBC,
cells  103/l
Neutrophils,
%WBC
Lymphocytes,
%WBC
Platelets,
cells  103/l
Controls
Baseline 5.20.4 47.72.8 1.610.48 6.40.8 60.84.9 27.54.0 24490
Half-marathon
Baseline 4.90.2 44.62.1* 0.760.41* 6.01.1 54.18.9 31.56.9 23244
End of race 4.90.3 45.51.4 1.840.86† 10.52.6† 67.09.7 23.68.7 31151†
Morning postrace 4.70.3 43.62.1 0.890.25 6.11.1 55.510.0 30.08.9 23444
Marathon
Baseline 4.80.2* 43.91.8* 0.800.59* 6.61.4 53.77.8 32.55.4 22434
End of race 4.80.3 43.81.7 1.590.25† 15.23.2† 82.35.0† 10.03.0† 29943†
Morning postrace 4.70.2 43.41.9 0.650.26 7.50.9 57.46.9 29.94.5 23045
Values are means  SD. RBC, red blood cells; WBC, white blood cells. Significant difference vs. *controls and †baseline, P  0.05.
Fig. 1. Total circulating CD34 cells and their subpopulations in
controls and runners at baseline. Values are means  SD. *Signif-
icant difference between groups by Mann-Whitney test, P  0.005.
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from 18.0  11.4 to 9.7  5.1 cells/l; P  0.001). A
similar trend was observed in CD34/HLA-DR and
CD34/CD33 subpopulations (P  0.05 for both) only
in M runners.
We asked whether changes in HPC counts during
recovery after the race (i.e., the change in cell counts
between the morning postrace minus end of race) cor-
related with exercise-associated release of cytokines
and growth factors. This hypothesis was not confirmed
for plasma cortisol, IL-6, and G-CSF, as their levels at
end of race did not correlate with total CD34 cells or
any subpopulation on the morning postrace. Con-
versely, the higher the level of flt3-ligand or TNF-
at the end of the race, the lower CD34/HLA-DR
and CD34/CD33 cell counts the morning postrace
(Fig. 4).
DISCUSSION
The main result of this study is that chronic hema-
topoietic adaptations occur in well-trained athletes, as
indicated by higher baseline circulating HPCs in run-
ners than in sedentary controls. The second result is
that HPCs did not change immediately after the race
but were decreased on the following morning. Plasma
cytokines and growth factors increased after both M
and HM races and correlated with some changes in
HPC counts observed the morning postrace, support-
ing the hypothesis that daily bouts of exercise, with
release of hormones and other mediators, may act as
chronic intermittent stimuli modulating HPCs in pe-
ripheral blood.
A marathon is an established model of exercise-
induced inflammation (6, 8, 16, 17, 23, 24). Exercise-
induced neutrophilia partly results from mobilization
of the marginated pool (5), secondary to increased
cardiac output and plasma cortisol (15). Running a
marathon increases plasma PMN elastase (8) and in-
duces a complex pattern of pro- and anti-inflammatory
mediators (17, 24), including cytokines and growth
factors known to affect hematopoiesis, supporting the
rationale of our study.
Circulating HPCs were unaffected acutely by the M
or HM. However, in both HM and M groups, subjects
with the highest CD34 counts at rest showed the
smallest change in CD34 cells at the end of the race
(Fig. 2A). Furthermore, the change in CD34 counts at
the end of the race in M runners correlated inversely
with training volume, strongly supporting a training
effect. Sedentary subjects undergoing a week of daily
exercise showed progressively blunted exercise-in-
duced neutrophilia and band cell release (22, 23). Our
observations on more immature blood cells support
exercise-dependent modulation of the early HPC pool.
However, no significant relationship could be demon-
strated between training volume and CD34 cell
counts at baseline.
Exercise-induced release of stress and inflammatory
mediators could be the link between exercise and mod-
Table 2. Total CD34 cells and their subpopulations in controls and runners
CD34 Total
CD34/
CD38
CD34/
CD38
CD34/
HLA-DR
CD34/
HLA-DR
CD34/
CD33
CD34/
CD33
Controls
Baseline 4.02.0 0.40.7 3.01.4 2.31.9 1.81.4 2.42.1 1.61.1
Half-marathon
Baseline 23.423.3* 0.91.1 22.023.3* 7.34.0* 14.620.1* 4.94.7 18.522.5*
End of race 17.513.1 1.32.1 15.614.8 10.711.5 6.53.3 12.310.8 4.43.2
Morning postrace 9.86.6† 1.21.2 7.96.0 6.26.9 3.91.7 7.16.2 2.71.1
Marathon
Baseline 15.57.6* 0.20.6 13.26.4* 10.78.2* 4.22.8 9.59.7 6.05.8*
End of race 18.610.5 1.31.6 14.79.7 10.66.1 5.04.6 14.48.8 4.24.1
Morning postrace 9.53.6† 0.50.6 8.13.2 5.42.9† 3.82.2 7.33.8† 2.21.7
Values are means  SD in cells/l. HLA, human leukocyte antigen. *Significant difference between controls and HM or M runners at
baseline (P  0.05 by Mann-Whitney test). †Significant difference between end of race and morning postrace (P  0.05 by paired t-test and
Bonferroni correction).
Fig. 2. Change in total CD34 cell counts at
the end of race vs. baseline total CD34
counts (A) and training volume (B). E, Half-
marathon (HM) runners; , marathon (M)
runners. A: the regression line refers to
pooled HM and M points (r  0.86, P 
0.001; regression on HM and M points only:
r0.89, P 0.005 and r0.76, P 0.05,
respectively). B: the regression line refers to
M points (r  0.88, P  0.005), as it was not
significant in the HM group.
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ulation of hematopoiesis. Changes in circulating HPC
counts appeared delayed compared with exercise-in-
duced release of mediators. Total CD34 cells de-
creased the morning postrace, together with CD34/
HLA-DR and CD34/CD33 subpopulation counts in
M runners. Plasma cortisol increased similarly after M
and HM and correlated with plasma levels of growth
factors known to act on the bone marrow. Our study is
Fig. 3. Inflammatory markers, cytokines, and hor-
mone and growth factors in controls (open bars) and
in runners (shaded bars, HM; solid bars, M) at
baseline, end of race, and morning postrace. TNF-,
tumor necrosis factor-; IL-6, interleukin-6; flt3-
ligand, fms-like tyrosine kinase-3-ligand; G-CSF,
granulocyte colony-stimulating factor. Values are
means  SD. *Significant changes compared with
baseline, P  0.01. Horizontal bars, significant dif-
ferences between HM and M groups.
Fig. 4. flt3-Ligand (top) and TNF-
(bottom) plasma levels at end of race
correlated inversely with CD34/hu-
man leukocyte antigen-DR (left) and
CD34/CD33 (right) cell counts on the
morning postrace. 	, Change. Symbols
are as described in Fig. 2 legend. Re-
gression lines refer to pooled HM and
M points.
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the first to report that plasma flt3-ligand, a known
activator of HPCs (13), doubled after exercise, irrespec-
tive of running distance. TNF-, G-CSF, and IL-6 are
all known to affect hematopoiesis (11, 18, 27). In hu-
mans, G-CSF is used to mobilize and apheretically
collect HPCs for transplantation and acts synergisti-
cally with IL-1, IL-3, and IL-6 on the bone marrow (11,
27). G-CSF-induced mobilization of HPCs was shown
to be mediated by release of elastase by PMNs in the
bone marrow (12). A similar mechanism may operate
in runners through exercise-induced PMN activation
and elastase release. IL-6 also modulates hematopoi-
etic cell growth and differentiation (11, 18) and is
released by exercising muscles (6). However, because
G-CSF and IL-6 increased less after HM than after M,
their role on HPCs might be relatively minor compared
with that of flt3-ligand. Indeed, the increase in flt3-
ligand during exercise correlated inversely with de-
creased CD34/HLA-DR and CD34/CD33 counts
on the morning postrace. Conversely, we found no
correlation between increased plasma IL-6 or G-CSF
after the race and changes in CD34 cells on the
morning postrace. However, because several signifi-
cant associations were found between plasma cortisol
and inflammatory markers, it is likely that both stress
and inflammation may come into play to modulate
HPC subpopulations in runners. Only circulating
CD34/CD38 cells were low in both runners and
controls, suggesting no effect of exercise on the very
early CD34 cell pool.
Data from M and HM runners were similar for many
variables. This is not surprising, because data after a
real competition reflect the best possible performance
in each runner, accounting for similar levels of mark-
ers of stress (cortisol) and muscle damage (enzymes) in
both groups. Conversely, peripheral blood neutro-
philia, IL-6, and G-CSF were higher after the M race
(16), supporting the fact that they were influenced by
the duration of exercise.
Because M runners were slightly older than HM
runners or controls, our conclusions may be affected at
least partly by an age effect. We consider this hypoth-
esis unlikely. CD34 cells tend to decrease with age,
but M runners showed higher, not lower, counts com-
pared with controls. In addition, CD34 cell counts did
not differ significantly between M and HM runners,
despite the significant age difference between groups.
An effect of age, instead, was apparent for flt3-ligand
at baseline in both runners and controls. The slight
increase in flt3-ligand levels could reflect decreasing
bone marrow sensitivity to this factor with age.
We are aware that circulating HPC subpopulations
reflect hematopoiesis only indirectly, and the precise
mechanism of increased HPCs in runners or the effects
of M or HM races on maturation of HPC cannot be
inferred by our data. Ethical limitations prevent ob-
taining bone marrow samples in healthy subjects. On
the other hand, our runners were not elite athletes,
and the results of this study represent physiological
responses in normal, healthy individuals.
The data prompt the question on the physiological
role of circulating HPCs in runners. It is possible that
increased “turnover” of polymorphonuclear cells asso-
ciated with exercise and the consequent inflammatory
state may stimulate HPC production and mobiliza-
tion; in this case, the decrease in HPC counts docu-
mented after the race might reflect maturation and
replenishment of the peripheral PMN compartment
after prolonged and intense exercise. Alternatively, we
speculate on a possible HPC involvement in angiogen-
esis and repair processes associated with exercise
and training. Circulating HPCs were involved in neo-
vascularization after myocardial damage in humans
(20) and include cells with an angioblastic potential
(19). Exercise is a potent cause of angiogenesis in
skeletal muscle (9), and circulating HPCs might con-
tribute to this process. Further studies with measure-
ments of specific markers of early endothelial or mus-
cle cell differentiation, however, are necessary to
support this hypothesis.
As for the possible HPC involvement in tissue repair,
it could apply to several tissues, including the lung, as
bone marrow stem cells can differentiate into alveolar
epithelium (10). In induced sputum of runners, we
found very high PMN counts after a marathon and a
pattern in PMN adhesion molecules, suggesting ongo-
ing repair postrace (4). Should our findings be con-
firmed, they may be relevant in exercise-based cardiac
and/or respiratory rehabilitation programs, as well as
in other diseases. A study in well-trained subjects,
however, cannot provide information on the exercise
threshold necessary to trigger hematopoietic adapta-
tions. This point deserves further study, together with
the molecular and functional characterization of HPCs
before and after training.
Opposite to the behavior of HPCs, runners appeared
to “spare” reticulocytes at rest and released them tran-
siently after exercise. Our data confirm the low-reticu-
locyte counts at rest in runners studied during a train-
ing period (14). The increase in reticulocytes after the
race correlated with plasma cortisol but was not asso-
ciated with changes in EPO, as already reported by
Bodary and coworkers (3). Besides stress, hemolysis
secondary to the mechanical impact of running (25)
could also modulate the reticulocyte response to exer-
cise.
In conclusion, HPC counts were increased in periph-
eral blood of runners at baseline and did not change
immediately after a M or HM race. Circulating CD34
cells decreased on the morning postrace, suggesting
modulation of hematopoiesis during recovery after in-
tense and prolonged exercise. Exercise-induced release
of inflammatory and stress mediators, together with
increased levels of hematopoietically active growth fac-
tors such as flt3-ligand, IL-6, and G-CSF, may be the
pathophysiological link between exercise and chroni-
cally increased circulating HPCs in runners. The po-
tential application of these findings to competitive
training and exercise-based rehabilitation programs
deserves further study.
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